|
Diagnosed
disease
|
Labelled
compound used
|
|
Gastrointestinal
tract diseases
|
| Presence
of Helicobacter pylori in a stomach |
13Ñ-urea |
| Excessive
growth of microflora of small intestine |
13Ñ-D-xylose,13Ñ-palmetic
acid, 13Ñ-linoleic acid
|
| Determination
of gastric peristalsis for liquid and semiliquid materials |
13Ñ-acetate
(sodium acetate) |
| Determination
of gastric peristalsis for solid materials |
13Ñ-octanoic
acid |
Mechanism
of lactose adaptation in children with lactose insufficiency
|
13Ñ-lactose |
| Fat
malabsorption |
Trioctanoine
-1-13Ñ |
| Pancreas
insufficiency |
Mixed
13Ñ-triglycerides |
| Monitoring
of enzyme-substitutive therapy |
Mixed
13Ñ-triglycerides |
|
Liver
diseases
|
| Hepatic
insufficiency |
13C-methacetin
Aromatic acids
|
| Cirrhosis
diagnostics |
13Ñ-galactose |
| Hepatic
grafts control |
13Ñ-methacetin
13Ñ-aminopyrine
|
|
Metabolic
disorders and endocrine diseases
|
| Thyroid
gland diseases |
13Ñ-acetate,
13Ñ-palmeate
|
| Initial
stages of growth-onset diabetes |
13Ñ-glucose |
| Examination
of amino acid metabolism |
13Ñ-leucine |
|
Other
diseases
|
| Determination
of activity of HLp-gene of Ð-450 cytochromes |
13Ñ-N-methyl-erythromycine |
| Steroid
hormones excessive content |
13Ñ-tryptophane |
| Leukemia |
13Ñ-asparagine |
| Myeloma |
|
Â12 deficiency |
13Ñ-propionate |